Literature DB >> 30033930

Case of EGPA and Eosinophilic Chronic Rhinosinusitis Concomitant with IgG4 Related Disease.

Kosuke Akiyama, Masafumi Yonezaki, Hiroaki Dobashi, Tomohiro Kameda, Hiroshi Hoshikawa, Norimitu Kadowaki.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis in patients with bronchial asthma and eosinophilic rhinosinusitis. Serum IgG4 levels are markedly elevated in patients with active EGPA, a disease which has been closely associated with IgG4-related disease (IgG4RD). A 68-year-old male with a history of asthma and eosinophilic rhinosinusitis developed vasculitis and orbital symptoms. The results of a laboratory examination showed eosinophilia (4,067/μl; 39%), while image evaluations revealed hypertrophy of the rectus muscles, trigeminal nerve, lachrymal gland, and bilateral submandibular glands. Biopsy of the paranasal sinus showed the prominent infiltration of eosinophils and IgG4-positive plasma cells. The patient was diagnosed with EGPA concomitant with IgG4RD and treated with systemic steroids. Although concomitant cases of EGPA with IgG4RD are extremely rare, clinical manifestations associated with both diseases are sometimes mixed. Therefore, systemic scrutiny may be required for cases of EGPA with high serum IgG4 levels and pathognomonic symptoms or findings of IgG4RD

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 30033930

Source DB:  PubMed          Journal:  Nihon Jibiinkoka Gakkai Kaiho        ISSN: 0030-6622


  1 in total

1.  A Case of Eosinophilic Granulomatosis with Polyangiitis Complicated with A IgG4 Related Disease Like Symptoms.

Authors:  Suguru Sato; Julia Morimoto; Yasuharu Oguchi; Takashi Umeda; Takaya Kawamata; Mami Rikimaru; Tatsuhiko Koizumi; Ryuichi Togawa; Yasuhito Suzuki; Yuki Sato; Manabu Uematsu; Hiroyuki Minemura; Takefumi Nikaido; Atsuro Fukuhara; Junpei Saito; Kenya Kanazawa; Yoshinori Tanino; Mitsuru Munakata; Yoko Shibata
Journal:  Case Reports Immunol       Date:  2018-11-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.